About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Morning Consult ran a survey, on behalf of PhRMA, among 1,990 national registered voters focusing on the potential expansion of the TRIPS waiver and the impact that would have on U.S. global leadership, jobs, and pharmaceutical innovation.
January 2024 Morning Consult Poll about TRIPS Waiver Expansion image
Report
Intellectual Property
January 2024 Morning Consult Poll about TRIPS Waiver Expansion
January 2024 Morning Consult Poll about TRIPS Waiver Expansion image